Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Nature Communications|May 23, 2013
Crystal structures of interleukin 17A and its complex with IL-17 receptor AShenping Liu, Xi Song, Boris A Chrunyk, et al.Proceedings of the National Academy of Sciences of the United States of America|December 8, 2010
Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosaSeungil Han, Richard P Zaniewski, Eric S Marr, et al.Acta Crystallographica. Section D, Biological Crystallography|December 8, 2009
A systematic study of 50S ribosomal subunit purification enabling robust crystallizationThomas J McLellan, Eric S Marr, Lillian M Wondrack, et al.Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolatesThomas V Magee, Seungil Han, Sandra P McCurdy, et al.Scientific Reports|April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRsNoelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.Scientific Reports|January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRsNoelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.Analytical Biochemistry|August 4, 2009
Purification of the large ribosomal subunit via its association with the small subunitSamuel P Simons, Thomas J McLellan, Paul A Aeed, et al.Journal of Medicinal Chemistry|January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitorsThomas A Chappie, John M Humphrey, Martin P Allen, et al.Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2008
Synthesis and structure based optimization of novel Akt inhibitorsBlaise Lippa, Gonghua Pan, Matthew Corbett, et al.Pageof 2